• Publications
  • Influence
Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996).
TLDR
On the basis of a low local recurrence rate and high median survival time, wide excision of tumor margins or radical surgery appeared to be an effective means for managing soft-tissue sarcomas of the trunk and extremities. Expand
Multilobular osteochondrosarcoma in 39 dogs: 1979-1993.
TLDR
Older, large-breed dogs with multilobular osteochondrosarcoma each presented primarily with a fixed mass involving the flat bones of the skull, and Histological grade, surgical margins, and tumor location affected outcome. Expand
Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999).
TLDR
Results suggest that additional local treatment may not be required after complete excision of grade-II mast cell tumors and that most dogs do not require systemic treatment. Expand
Massive hepatocellular carcinoma in dogs: 48 cases (1992-2002).
TLDR
Liver lobectomy is recommended for dogs with massive HCC because tumor-related mortality rate was 15.4 times higher in dogs in the nonsurgery group, compared with the surgery group and tumor control was excellent after surgical resection with no local recurrence and a low metastatic rate. Expand
Doxorubicin and BAY 12-9566 for the treatment of osteosarcoma in dogs: a randomized, double-blind, placebo-controlled study.
TLDR
Doxorubicin is an effective adjuvant to amputation in prolonging survival for dogs with appendicular osteosarcoma and as the number of mitotic figures in the biopsy increased, the risk of dying increased. Expand
Treatment with a combination of doxorubicin, surgery, and radiation versus surgery and radiation alone for cats with vaccine-associated sarcomas: 25 cases (1995-2000).
TLDR
The efficacy of doxorubicin in the treatment of vaccine-associated sarcomas is uncertain and significant differences between the 2 treatment groups were not detected. Expand
Cortical allograft and endoprosthesis for limb-sparing surgery in dogs with distal radial osteosarcoma: a prospective clinical comparison of two different limb-sparing techniques.
TLDR
For dogs with OSA of the distal aspect of the radius, a cortical allograft or endoprosthesis can be used for limb-sparing surgery and construct failure and postoperative infection significantly improve survival time regardless of implant type. Expand
Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs.
TLDR
Carboplatin treatment improves the survival probability in dogs with appendicular OSA compared to amputation alone and remains an acceptable alternative to adjuvant treatment with cisplatin. Expand
Improved Survival Associated With Postoperative Wound Infection in Dogs Treated With Limb-Salvage Surgery for Osteosarcoma
TLDR
In dogs with osteosarcoma treated with limb-salvage surgery, infection has a positive influence on survival, as does a smaller initial length of radius involved and lower body weight. Expand
...
1
2
3
4
5
...